Patents by Inventor Genevieve Motte

Genevieve Motte has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6255487
    Abstract: The present invention relates to novel substituted [2-(1-piperazinyl)-ethoxy]methyl compounds of formula in which R1 represents a —CONH2, —CN, —COOH, —COOM or —COOR3 group, M being an alkali metal and R3 being an alkyl radical having from 1 to 4 carbon atoms; and R2 represents a hydrogen atom or a group —COR4 or —R5, where R4 is chosen from the groups —OR6 l or —R7, in which R5 represents an alkyl or alkylaryl radical, R6 represents a linear or branched alkyl radical having from 1 to 4 carbon atoms, a haloalkyl, alkylaryl, alkylnitroaryl or alkylhaloaryl radical, and R7 represents a haloalkyl radical, to a process for the preparation of these compounds, and to their use for the preparation of compounds which are themselves valuable intermediates for the preparation of 2-[2-[4[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-acetic acid or 2-[2-[4-[bix(4-fluorophenyl)methyl&rs
    Type: Grant
    Filed: March 21, 2000
    Date of Patent: July 3, 2001
    Assignee: UCB, S.A.
    Inventors: Guy Duchene, Michel Deleers, Guy Bodson, Genevieve Motte, Francoise Lurquin
  • Patent number: 6140501
    Abstract: Novel substituted [2-(1-piperazinyl)ethoxy]methyl compounds.The present invention related to novel substituted [2-(1-piperazinyl)-ethoxy]methyl compounds of formula ##STR1## in which R.sub.1 represents a --CONH.sub.2, --CN, --COOH, --COOM or --COOR.sub.3 group, M being an alkali metal and R.sub.3 being an alkyl radical having from 1 to 4 carbon atoms; andR.sub.2 represents a hydrogen atom or a group --COR.sub.4 or --R.sub.5, where R.sub.4 is chosen from the groups --OR.sub.6 or --R.sub.7, in whichR.sub.5 represents an allyl or alkylaryl radical,R.sub.6 represents a linear or branched alkyl radical having from 1 to 4 carbon atoms, a haloalkyl, alkylaryl, alkylnitroaryl or alkylhaloaryl radical, andR.sub.
    Type: Grant
    Filed: October 9, 1998
    Date of Patent: October 31, 2000
    Assignee: UCB, S.A.
    Inventors: Guy Duchene, Michel Deleers, Guy Bodson, Genevieve Motte, Francoise Lurquin
  • Patent number: 5658938
    Abstract: Substituted 4-(1,2,3,4-tetrahydro-1-naphthalenyl)-1H-imidazoles and 4-(2,3-dihydro-1H-inden-1-yl)-1H-imidazoles, their optical isomers and their racemic mixtures, their salts, methods for preparing them and therapeutic compositions containing them. These compounds have the general formula ##STR1## wherein n=1 or 2,R.sub.1, R.sub.2, R.sub.3 and R.sub.4 =hydrogen, halogen, hydroxyl C.sub.1 -C.sub.4 alkyl or C.sub.1 -C.sub.4 alkoxy,R.sub.5 = hydrogen of C.sub.1 -C.sub.4 alkyl with the proviso that R.sub.1, R.sub.2, R.sub.3, R.sub.4 and R.sub.5, cannot simultaneously be hydrogen when n is equal to 2.These new compounds exhibit anti-ischemic and anti-hypertensive activities.
    Type: Grant
    Filed: December 8, 1995
    Date of Patent: August 19, 1997
    Assignee: U C B S.A.
    Inventors: Jean-Pierre Geerts, Genevieve Motte, Edmond Differding, Jean-Pierre Henichart